Brief: Comera Life Sciences Announces Research Collaboration With Top 10 Pharmaceutical Company To Develop Subcutaneous Formulation
09/05/2022 13:16
May 9 (Reuters) - Comera Life Sciences Inc:
* COMERA LIFE SCIENCES ANNOUNCES RESEARCH COLLABORATION WITH
TOP
10 PHARMACEUTICAL COMPANY TO DEVELOP SUBCUTANEOUS FORMULATION
* COMERA LIFE SCIENCES- FINANCIAL TERMS OF COLLABORATION
WERE NOT
DISCLOSED
Source text for Eikon: ID:nBw8kzr1ga
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Comera Life Sciences Holdings
See all newsBrief: Comera Life Sciences Holdings Says William Wexler Resigned From Company's Board Of Directors Effective Immediately
Brief: Comera Life Sciences Announces Process Exploring Strategic Alternatives
Brief: Comera Life Sciences Holdings - On Nov 15, Got Notice From Nasdaq That Nasdaq Hearings Panel Has Determined To Delist Common Stock And Warrants Of Co
Brief: Comera Life Sciences Appoints Dorothy Clarke To Board Of Directors
Brief: Comera Life Sciences Announces Completion Of $4.1 Million Private Placement